recurrent ovarian epithelial cancer

基本解釋

Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?
用貝伐單抗治療復發(fā)性卵巢上皮癌的患者中，哪種因素可以預測腸道并發(fā)癥？
173822.china-obgyn.net
Objective To evaluate the efficiency and safety of liposomal doxorubicin in the treatment of recurrent epithelial ovarian cancer.
目的評價脂質體阿霉素在復發(fā)性卵巢上皮性癌二線化療治療中的有效性和安全性。
Objective:To compare the difference of efficacy and toxicity between weekly and monthly paclitaxel therapy in combination with platinum for treatment of recurrent ovarian epithelial cancer.
目的比較紫杉醇為主的聯合化療在治療復發(fā)卵巢上皮癌時，紫杉醇周療與月療不同給藥方法的近期療效、復發(fā)后生存時間及毒副作用。